Al­ny­lam sues Mod­er­na and Pfiz­er again over Covid-19 vac­cine patent in­fringe­ment

The patent bat­tle over Covid-19 vac­cine de­liv­ery tech­nol­o­gy in­ten­si­fied yes­ter­day af­ter Al­ny­lam Phar­ma­ceu­ti­cals yet again ac­cused Mod­er­na and Pfiz­er of vi­o­lat­ing patents.

In two sep­a­rate …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER